Net Income (Loss) Per Share (Tables)

6 Months Ended

Jun. 30, 2023

For periods in which the Company reports net losses, basic and diluted net loss per share are the same because potentially dilutive common shares are not assumed to have been issued if their effect is anti-dilutive.


	Three Months Ended June 30,				Six Months Ended June 30,
	2022		2023		2022		2023
Numerator:
Net income (loss)	$	(29,871)	$	(28,165)	$	2,821	$	(157,419)






Denominator:
Weighted-average common shares outstanding used to calculate net income (loss) per share, basic	83,833,963		83,130,638		84,031,109		82,524,403
Weighted-average effect of dilutive securities	—		—		10,477,951		—
Weighted-average common shares outstanding used to calculate net income (loss) per share, diluted	83,833,963		83,130,638		94,509,060		82,524,403

Net income (loss) per share, basic	$	(0.36)	$	(0.34)	$	0.03	$	(1.91)
Net income (loss) per share, diluted	$	(0.36)	$	(0.34)	$	0.03	$	(1.91)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities were excluded from the computation of diluted net income (loss) per share for the periods presented, due to their anti-dilutive effect. These amounts represent the number of instruments outstanding at the end of each respective quarter:


	Three Months Ended June 30,		Six Months Ended June 30,
	2022	2023	2022	2023

Options to purchase common stock	11,138,435	13,370,041	770,852	13,370,041
Unvested RSUs	2,497,064	7,274,949	2,061,568	7,274,949
Unvested PRSUs	687,500	—	687,500	—
Purchase rights committed under the ESPP	216,088	166,384	—	166,384

Convertible debt	2,318,078	2,318,078	2,318,078	2,318,078

Total	16,857,165	23,129,452	5,837,998	23,129,452